Press Release
Bolt Biotherapeutics Prices Upsized Initial Public Offering
Press Release
Bolt Biotherapeutics Expands Board of Directors with Appointment of Kathleen LaPorte
Press Release
Bolt Biotherapeutics Presents Ongoing Clinical Trial Poster at San Antonio Breast Cancer Symposium 2020 Virtual Meeting
Press Release
Data Published in Nature Cancer Highlight Preclinical Proof of Concept of Bolt Biotherapeutics’ Boltbody™ ISAC Platform
Press Release
Bolt Biotherapeutics Presents BDC-1001 Ongoing Clinical Trial Design and Supportive Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting
Press Release
Bolt Biotherapeutics Closes $93.5 Million Series C Financing
Press Release
Bolt Biotherapeutics Announces Issuance of U.S. Patent for the Boltbody™ ISAC Technology and its Lead Development Candidate, BDC-1001
Press Release
Bolt Biotherapeutics Appoints William P. Quinn as Chief Financial Officer
Press Release
Bolt Biotherapeutics Appoints Edith Perez, M.D., as Chief Medical Officer
Press Release
Bolt Biotherapeutics Appoints Nathan Ihle, Ph.D., as Vice President of CMC and Quality